Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamsulosin vs tamsulosin plus isosorbide dinitrate for trial without catheter in acute urinary retention due to BPH
IRCT2017041724606N3Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in acute urinary retention and benign prostatic hyperplasia (BPH) comparing Tamsulosin monotherapy with Tamsulosin plus isosorbide dinitrate (2 arms). Primary endpoint: TWOC success rate. Started Nov 2016; status: completed.
02
Drugs
tamsulosinisosorbide dinitrate
03
Conditions
acute urinary retentionbenign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on IRCT2017041724606N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017041724606N3.